Descriptive Study of the Reconstruction of Osteochondral Lesions of the Knee: Clinical and Imaging Results

Osteochondral Defect Clinical Trial

Official title:

Descriptive Study of the Reconstruction of Osteochondral Lesions of the Knee: Clinical and Imaging Results

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03908931
• Other study ID #: P19/02
• Status: Recruiting
• Phase: N/A
• Start date: April 1, 2019
• Est. completion date: June 1, 2020

Study information

• Verified date: April 2019
• Source: Versailles Hospital
• Contact: Nicolas PUJOL
• Phone: +33139639565
• Email: npujol[@]ch-versailles.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the clinical results and MRI imaging of autologous cartilage reconstructions or collagen matrix of the knee.

There is currently little data in the literature on clinical outcomes and imaging of this type of lesion.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 130
• Est. completion date: June 1, 2020
• Est. primary completion date: April 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• cartilaginous reconstruction by autologous transplant or collagenous chondro-inducing knee matrix

• > 18 years

Exclusion Criteria:

• Other cartilaginous reconstruction techniques,

• other than knee joint

Related Conditions & MeSH terms

• Osteochondral Defect

Intervention

Radiation:
• MRI
Follow up of osteochondral surgery by MRI and clinical examination

Locations

Country	Name	City	State
France	CH de Versailles	Le Chesnay

Sponsors (1)

Lead Sponsor	Collaborator
Versailles Hospital

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postoperative knee function assessed by clinical examination		2 years post surgery
Primary	Postoperative knee function assessed by scores		2 years post surgery